Shire faces reverse-payment lawsuit over ADHD medication

An independent South Carolina pharmacy has filed a class action complaint against Shire for entering into an agreement with Actavis to allegedly keep a generic version of its brand-name attention deficit hyperactivity disorder medication off the market.

Unlock unlimited access to all Global Competition Review content